Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

brecon_kay_ohagan

Boehringer’s Kay O’Hagan moves to Brecon

March 2, 2011 Manufacturing and Production, Research and Development Brecon, Kay O'Hagan, appointment, manufacturing and production, research and development

Kay O’Hagan has joined commercial packaging and clinical trials supply services company Brecon Pharmaceuticals as director of quality assurance and …
Appointment

GlaxoSmithKline seeks alliances with ‘academic superstars’

March 2, 2011 Research and Development GSK, GlaxoSmithKline, Pentraxin Therapeutics, academia, al Free and University College Medical School, universities

GlaxoSmithKline has unveiled a partnership with a ‘superstar academic’, as part of a new strategy which it believes will help …
News

Daiichi Sankyo gains rights to potential blockbuster cancer drug

March 2, 2011 Research and Development BRAF protein, Daiichi Sankyo, PLX4032, Plexxikon, melanoma, personalised medicine

Daiichi Sankyo has purchased US-based discovery firm Plexxikon for $805 million, gaining access to its potential blockbuster melanoma drug PLX4032. …
News
Bayer's Marijn Dekkers

Bayer goes for pharma growth

March 1, 2011 Research and Development, Sales and Marketing 2010 pharma results, Bayer, Dr Jörg Reinhardt, Marijn Dekkers, Nexavar, VEGF Trap-Eye, Xarelto

While many of its larger peers in the pharma sector are rushing to diversify into consumer health and generics, Bayer, …
Feature

Pfizer drops 15 pipeline projects

March 1, 2011 Research and Development Lyrica, Pfizer, Pfizer R&D, Pfizer product pipeline, Pfizer research, inotuzumab, pregabalin

Pfizer has again slimmed down its product pipeline as the US giant looks to cut R&D spending and sharpen its …
News

Friedhelm Felten to head procurement at Merck

March 1, 2011 Manufacturing and Production, Research and Development Friedhelm Felten, Merck KGaA, appointment, manufacturing and production, research and development

Merck KGaA has appointed Friedhelm Felten as its new head of corporate procurement with responsibility for the group’s global purchasing …
Appointment

Forest depression candidate struggles against placebo

March 1, 2011 Research and Development Forest, Forest Laboratories, Gedeon Richter, cariprazine, depression, major depressive disorder

An investigational antipsychotic drug being developed by Forest Laboratories and Budapest-based Gedeon Richter has failed to prove itself in phase …
News

Pfizer in break up talks for Sandwich research site

March 1, 2011 Research and Development Kent, Pfizer, Sandwich, job cuts

Pfizer is in confidential talks over the future of its Sandwich, Kent research facility that could see the site broken …
News

Service Insight: Discovery metrics – creating the right balance

February 28, 2011 Research and Development Atkinson Cowan, Kinapse, Service Insight, metrics, research and development

SERVICE INSIGHTMetrics can be powerful tools for driving performance in organisations and have proliferated in the pharmaceutical industry over the …
Feature
viiv_gsk_pfizer_david_redfern

David Redfern appointed ViiV chairman

February 28, 2011 Research and Development, Sales and Marketing David Redfern, GSK, GlaxoSmithKline, Pfizer, ViiV, ViiV Healthcare, appointment, research and development, sales and marketing

David Redfern has been appointed as chairman of ViiV Healthcare, the joint GlaxoSmithKline-Pfizer venture focused on HIV.
Appointment

Vertex’s cystic fibrosis drug shows huge promise

February 28, 2011 Research and Development, Sales and Marketing VX-770, Vertex, cystic fibrosis

US pharma company Vertex has announced extremely promising results for a drug that could be a major advance in treating …
News

New agreement seeks to speed up UK research

February 25, 2011 Research and Development BIA, Industry Collaborative Research Agreement, MRC, Medical Research Council, National Institute for Health Research, Office for Clinical Research Infrastructure, UK research, clinical research, mICRA

The government has revised the research contracting process in a bid to streamline research between pharma and biotech companies, universities …
News
Pfizer research Sandwich, Kent

MPs to question Pfizer management over R&D closure

February 25, 2011 Research and Development Kent, Pfizer, Sandwich, Science and Technology Select Committee, research and development

Senior Pfizer executives will appear before MPs next week to answer questions on the closure of the company’s Kent research …
News

Glioblastoma vaccine enters phase II

February 24, 2011 Research and Development Cancer, GBM, ImmunoCellular Therapeutics, oncology

The first patient has been enrolled in a phase II trial of ICT-107, a cancer vaccine candidate for the treatment …
News
Roche building

Roche pulls out of vaccine alliance with Transgene

February 23, 2011 Research and Development HPV, HPV vaccine, Roche, TG4001, Transgene, cervical cancer, cervical lesions, human papilloma virus, vaccines

Roche has terminated its license agreement with Transgene for its HPV therapeutic vaccine TG4001. The vaccine is currently being tested …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026